Avanos Medical Inc
Buy, Hold or Sell?
Let's analyze Avanos together
I guess you are interested in Avanos Medical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.
I'm going to help you getting a better view of Avanos Medical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.
Get notifications about Avanos Medical Inc
I send you an email if I find something interesting about Avanos Medical Inc.
1. Quick Overview
1.1. Quick analysis of Avanos (30 sec.)
1.2. What can you expect buying and holding a share of Avanos? (30 sec.)
How much money do you get?
What is your share worth?
+ What do you gain per year?
2. Detailed Analysis
2.1. Valuation of Avanos (5 min.)
2.2. Growth of Avanos (5 min.)
2.3. Financial Health of Avanos (5 min.)
2.4. Comparing to competitors in the Medical Devices industry (5 min.)
Industry Rankings (Medical Devices)
3. Summary and Key Metrics
3.1. What can you expect buying and holding a share of Avanos?
Welcome investor! Avanos's management wants to use your money to grow the business. In return you get a share of Avanos.
First you should know what it really means to hold a share of Avanos. And how you can make/lose money.
Speculation
The Price per Share of Avanos is $17.97. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.
If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:
- The fundamentals: the financial health trends of Avanos.
- The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
- The book value: what is the market price compared to it's book value.
Investing
If you really want to invest in Avanos, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:
- You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $26.39. Based on the TTM, the Book Value Change Per Share is $0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.19 per quarter.
- You may receive quarterly/yearly dividend in the form of additional shares.
- You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
How much money are you going to get?
MRQ | TTM | YOY | 5Y | 10Y | ||||||
---|---|---|---|---|---|---|---|---|---|---|
$ | % of Price per Share | $ | % of Price per Share | $ | % of Price per Share | $ | % of Price per Share | $ | % of Price per Share | |
Usd Eps | 0.09 | 0.5% | 0.08 | 0.5% | -0.29 | -1.6% | -0.04 | -0.2% | -0.16 | -0.9% |
Usd Book Value Change Per Share | 0.00 | 0.0% | 0.07 | 0.4% | -0.19 | -1.1% | -0.01 | 0.0% | -0.46 | -2.5% |
Usd Dividend Per Share | 0.00 | 0.0% | 0.00 | 0.0% | 1.50 | 8.4% | 0.31 | 1.7% | 0.95 | 5.3% |
Usd Total Gains Per Share | 0.00 | 0.0% | 0.07 | 0.4% | 1.31 | 7.3% | 0.31 | 1.7% | 0.49 | 2.7% |
Usd Price Per Share | 24.03 | - | 21.57 | - | 25.65 | - | 29.33 | - | 35.64 | - |
Price to Earnings Ratio | 65.10 | - | -9.36 | - | -185.80 | - | -38.96 | - | -12.30 | - |
Price-to-Total Gains Ratio | -5,138.42 | - | -1,194.13 | - | 20.58 | - | -46.24 | - | 719.24 | - |
Price to Book Ratio | 0.91 | - | 0.81 | - | 0.95 | - | 1.11 | - | 1.36 | - |
Price-to-Total Gains Ratio | -5,138.42 | - | -1,194.13 | - | 20.58 | - | -46.24 | - | 719.24 | - |
When do you get the money?
Usd Investment | |
---|---|
Usd Price Per Share | 17.97 |
Number of shares | 55 |
Gains per Quarter | Trailing 12 Months | 5 Year |
---|---|---|
Usd Dividend Per Share | 0.00 | 0.31 |
Usd Book Value Change Per Share | 0.07 | -0.01 |
Usd Total Gains Per Share | 0.07 | 0.31 |
Gains per Quarter (55 shares) | 3.78 | 16.78 |
Gains per Year (55 shares) | 15.13 | 67.13 |
Years | Return on Investment (TTM) | Return on Investment (5Y) | ||||
---|---|---|---|---|---|---|
Dividend | Book Value gain | Total gains | Dividend | Book Value gain | Total gains | |
Broker costs | - | - | -10 | - | - | -10 |
1 | 0 | 15 | 5 | 69 | -2 | 57 |
2 | 0 | 30 | 20 | 138 | -4 | 124 |
3 | 0 | 45 | 35 | 207 | -6 | 191 |
4 | 0 | 61 | 50 | 276 | -8 | 258 |
5 | 0 | 76 | 65 | 345 | -9 | 325 |
6 | 0 | 91 | 80 | 414 | -11 | 392 |
7 | 0 | 106 | 95 | 483 | -13 | 459 |
8 | 0 | 121 | 110 | 552 | -15 | 526 |
9 | 0 | 136 | 125 | 621 | -17 | 593 |
10 | 0 | 151 | 140 | 690 | -19 | 660 |
How sure are you?
Based on the past periods, how sure are you to get value out of your investment.
Linear %
Trailing 12 Months | 3Y | 5 Year | 10 Year | ALLTIME | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | % | % | % | % | ||||||||||||||||
Earnings Per Share | 3.0 | 1.0 | 0.0 | 75.0% | 8.0 | 4.0 | 0.0 | 66.7% | 11.0 | 9.0 | 0.0 | 55.0% | 26.0 | 14.0 | 0.0 | 65.0% | 32.0 | 16.0 | 0.0 | 66.7% |
Book Value Change Per Share | 2.0 | 2.0 | 0.0 | 50.0% | 7.0 | 5.0 | 0.0 | 58.3% | 10.0 | 10.0 | 0.0 | 50.0% | 25.0 | 15.0 | 0.0 | 62.5% | 29.0 | 17.0 | 2.0 | 60.4% |
Dividend per Share | 0.0 | 0.0 | 4.0 | 0.0% | 5.0 | 0.0 | 7.0 | 41.7% | 7.0 | 0.0 | 13.0 | 35.0% | 12.0 | 0.0 | 28.0 | 30.0% | 12.0 | 0.0 | 36.0 | 25.0% |
Total Gains per Share | 2.0 | 2.0 | 0.0 | 50.0% | 8.0 | 4.0 | 0.0 | 66.7% | 12.0 | 8.0 | 0.0 | 60.0% | 28.0 | 12.0 | 0.0 | 70.0% | 32.0 | 14.0 | 2.0 | 66.7% |
3.2. Key Performance Indicators
The key performance indicators of Avanos Medical Inc compared to the Most Recent Quarter (MRQ).
End of day | +/- | Most Recent Quarter | Trailing 12 Months | +/- | Year-Over-Year | +/- | 5 Year | +/- | 10 Year | +/- | |
---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Change Per Share | - | - | -0.005 | 0.069 | -107% | -0.192 | +4015% | -0.009 | +83% | -0.458 | +9687% |
Book Value Per Share | - | - | 26.388 | 26.472 | 0% | 26.960 | -2% | 26.517 | 0% | 26.319 | +0% |
Current Ratio | - | - | 2.220 | 2.213 | +0% | 2.946 | -25% | 2.768 | -20% | 2.556 | -13% |
Debt To Asset Ratio | - | - | 0.258 | 0.263 | -2% | 0.270 | -5% | 0.264 | -2% | 0.334 | -23% |
Debt To Equity Ratio | - | - | 0.347 | 0.356 | -3% | 0.370 | -6% | 0.360 | -4% | 0.532 | -35% |
Dividend Per Share | - | - | - | - | 0% | 1.502 | -100% | 0.314 | -100% | 0.951 | -100% |
Enterprise Value | - | - | 782298000.000 | 650018500.000 | +20% | 836477000.000 | -6% | 1060250800.000 | -26% | 1199145566.000 | -35% |
Eps | - | - | 0.092 | 0.084 | +10% | -0.293 | +417% | -0.037 | +140% | -0.160 | +273% |
Ev To Ebitda Ratio | - | - | 8.015 | 6.832 | +17% | 13.669 | -41% | 12.272 | -35% | 33.194 | -76% |
Ev To Sales Ratio | - | - | 1.148 | 0.953 | +20% | 1.114 | +3% | 1.437 | -20% | 1.417 | -19% |
Free Cash Flow Per Share | - | - | 0.429 | 0.197 | +118% | 0.195 | +121% | 0.157 | +174% | 0.083 | +417% |
Free Cash Flow To Equity Per Share | - | - | 0.086 | -0.535 | +724% | 0.187 | -54% | -0.039 | +146% | -0.176 | +305% |
Gross Profit Margin | - | - | 1.000 | 1.000 | 0% | 1.000 | 0% | 0.797 | +25% | 0.898 | +11% |
Intrinsic Value_10Y_max | - | - | 20.317 | - | - | - | - | - | - | - | - |
Intrinsic Value_10Y_min | - | - | 4.669 | - | - | - | - | - | - | - | - |
Intrinsic Value_1Y_max | - | - | 1.279 | - | - | - | - | - | - | - | - |
Intrinsic Value_1Y_min | - | - | 0.357 | - | - | - | - | - | - | - | - |
Intrinsic Value_3Y_max | - | - | 4.419 | - | - | - | - | - | - | - | - |
Intrinsic Value_3Y_min | - | - | 1.176 | - | - | - | - | - | - | - | - |
Intrinsic Value_5Y_max | - | - | 8.255 | - | - | - | - | - | - | - | - |
Intrinsic Value_5Y_min | - | - | 2.100 | - | - | - | - | - | - | - | - |
Market Cap | 825847290.000 | -36% | 1119798000.000 | 1001793500.000 | +12% | 1200052000.000 | -7% | 1394350800.000 | -20% | 1687853066.000 | -34% |
Net Profit Margin | - | - | 0.025 | 0.023 | +11% | -0.087 | +445% | -0.013 | +150% | -0.027 | +206% |
Operating Margin | - | - | 0.075 | 0.074 | +1% | 0.034 | +118% | 0.023 | +229% | 0.029 | +153% |
Operating Ratio | - | - | 0.902 | 0.909 | -1% | 0.968 | -7% | 0.975 | -7% | 0.947 | -5% |
Pb Ratio | 0.681 | -34% | 0.911 | 0.815 | +12% | 0.949 | -4% | 1.107 | -18% | 1.356 | -33% |
Pe Ratio | 48.686 | -34% | 65.105 | -9.356 | +114% | -185.802 | +385% | -38.965 | +160% | -12.301 | +119% |
Price Per Share | 17.970 | -34% | 24.030 | 21.573 | +11% | 25.645 | -6% | 29.330 | -18% | 35.636 | -33% |
Price To Free Cash Flow Ratio | 10.468 | -34% | 13.997 | 10.987 | +27% | -14.241 | +202% | -28.471 | +303% | -44.665 | +419% |
Price To Total Gains Ratio | -3842.588 | +25% | -5138.419 | -1194.134 | -77% | 20.577 | -25072% | -46.244 | -99% | 719.244 | -814% |
Quick Ratio | - | - | 1.038 | 1.016 | +2% | 1.508 | -31% | 1.558 | -33% | 1.448 | -28% |
Return On Assets | - | - | 0.003 | 0.002 | +11% | -0.008 | +426% | -0.001 | +146% | -0.004 | +271% |
Return On Equity | - | - | 0.003 | 0.003 | +10% | -0.011 | +425% | -0.002 | +143% | -0.008 | +338% |
Total Gains Per Share | - | - | -0.005 | 0.069 | -107% | 1.310 | -100% | 0.305 | -102% | 0.493 | -101% |
Usd Book Value | - | - | 1229700000.000 | 1228975000.000 | +0% | 1261700000.000 | -3% | 1256935000.000 | -2% | 1244415000.000 | -1% |
Usd Book Value Change Per Share | - | - | -0.005 | 0.069 | -107% | -0.192 | +4015% | -0.009 | +83% | -0.458 | +9687% |
Usd Book Value Per Share | - | - | 26.388 | 26.472 | 0% | 26.960 | -2% | 26.517 | 0% | 26.319 | +0% |
Usd Dividend Per Share | - | - | - | - | 0% | 1.502 | -100% | 0.314 | -100% | 0.951 | -100% |
Usd Enterprise Value | - | - | 782298000.000 | 650018500.000 | +20% | 836477000.000 | -6% | 1060250800.000 | -26% | 1199145566.000 | -35% |
Usd Eps | - | - | 0.092 | 0.084 | +10% | -0.293 | +417% | -0.037 | +140% | -0.160 | +273% |
Usd Free Cash Flow | - | - | 20000000.000 | 9150000.250 | +119% | 9150000.000 | +119% | 7430000.050 | +169% | 3755000.025 | +433% |
Usd Free Cash Flow Per Share | - | - | 0.429 | 0.197 | +118% | 0.195 | +121% | 0.157 | +174% | 0.083 | +417% |
Usd Free Cash Flow To Equity Per Share | - | - | 0.086 | -0.535 | +724% | 0.187 | -54% | -0.039 | +146% | -0.176 | +305% |
Usd Market Cap | 825847290.000 | -36% | 1119798000.000 | 1001793500.000 | +12% | 1200052000.000 | -7% | 1394350800.000 | -20% | 1687853066.000 | -34% |
Usd Price Per Share | 17.970 | -34% | 24.030 | 21.573 | +11% | 25.645 | -6% | 29.330 | -18% | 35.636 | -33% |
Usd Profit | - | - | 4300000.000 | 3925000.000 | +10% | -13850000.000 | +422% | -1745000.000 | +141% | -8170000.000 | +290% |
Usd Revenue | - | - | 170400000.000 | 170375000.000 | +0% | 187475000.000 | -9% | 184155000.000 | -7% | 226522500.000 | -25% |
Usd Total Gains Per Share | - | - | -0.005 | 0.069 | -107% | 1.310 | -100% | 0.305 | -102% | 0.493 | -101% |
EOD | +5 -3 | MRQ | TTM | +26 -11 | YOY | +18 -21 | 5Y | +20 -20 | 10Y | +22 -18 |
3.3 Fundamental Score
Penke's Stock Scanner
Indicator | Condition | Value | ||
---|---|---|---|---|
Price to Earnings Ratio (EOD) | Between | 0-15 | 48.686 | |
Price to Book Ratio (EOD) | Between | 0-1 | 0.681 | |
Net Profit Margin (MRQ) | Greater than | 0 | 0.025 | |
Operating Margin (MRQ) | Greater than | 0 | 0.075 | |
Quick Ratio (MRQ) | Greater than | 1 | 1.038 | |
Current Ratio (MRQ) | Greater than | 1 | 2.220 | |
Debt to Asset Ratio (MRQ) | Less than | 1 | 0.258 | |
Debt to Equity Ratio (MRQ) | Less than | 1 | 0.347 | |
Return on Equity (MRQ) | Greater than | 0.15 | 0.003 | |
Return on Assets (MRQ) | Greater than | 0.05 | 0.003 | |
Total | 7/10 (70.0%) |
3.4 Technical Score
Penke's Symbol Scanner
Indicator | Condition | Value | ||
---|---|---|---|---|
Rsi | Greater than | 50 | 34.893 | |
Ma 20 | Greater than | Ma 50 | 18.667 | |
Ma 50 | Greater than | Ma 100 | 20.351 | |
Ma 100 | Greater than | Ma 200 | 21.937 | |
Open | Greater than | Close | 18.340 | |
Total | 2/5 (40.0%) |
4. In-depth Analysis
4.1 About Avanos Medical Inc
- https://avanos.com
- Medical Devices
- 3771
- 5405 Windward Parkway, Alpharetta, GA, United States, 30004
Google Maps Bing Maps
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Fundamental data was last updated by Penke on 2024-12-07 15:56:05.
4.2 In-depth Summary
4.2.1. Financial Health Summary
Compared to previous year | Compared to industry | |
---|---|---|
The company is making a profit. | ||
Using its assets, the company is inefficient in making profit. | ||
Using its investors money, the company is inefficient in making profit. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is operating less efficient. | ||
The company is less efficient in keeping operating costs low. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is able to pay all its short-term debts. | ||
The company is just able to pay all its short-term debts with the most liquid assets. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is very able to pay all its debts by selling its assets. | ||
The company is very able to pay all its debts with equity. |
4.2.2. Valuation Summary
Compared to previous year | Compared to industry | |
---|---|---|
Based on the equity, the company is cheap. | ||
Based on the earnings, the company is expensive. | ||
Based on how much money comes from the company's main activities, the company is cheap. |
4.3 Financial Health
4.3.1. Profitability
4.3.1 Profitability
4.3.1.1. Net Profit Margin
- Above 10% is considered healthy but always compare Avanos to the Medical Devices industry mean.
- A Net Profit Margin of 2.5% means that $0.03 for each $1 in revenue is generated as profit.
Let's take a look of the Net Profit Margin trends of Avanos Medical Inc:
Trends
- The YOY is -8.7%. Compared to the TTM, the mid term is trending up. +2
- The 5Y is -1.3%. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -2.7%. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 2.5% | TTM | 2.3% | +0.3% | |
TTM | 2.3% | YOY | -8.7% | +11.0% | |
TTM | 2.3% | 5Y | -1.3% | +3.5% | |
5Y | -1.3% | 10Y | -2.7% | +1.4% |
Compared to industry (Medical Devices)
Let compare the company's Net Profit Margin with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -6.4%. trending up. +2
- The TTM average (mean) in the Medical Devices industry is -14.6%. trending up. +2
4.3.1.2. Return on Assets
- Above 5% is considered healthy but always compare Avanos to the Medical Devices industry mean.
- 0.3% Return on Assets means that Avanos generated $0.00 profit for each $1 in assets.
Let's take a look of the Return on Assets trends of Avanos Medical Inc:
Trends
- The YOY is -0.8%. Compared to the TTM, the mid term is trending up. +2
- The 5Y is -0.1%. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -0.4%. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.3% | TTM | 0.2% | +0.0% | |
TTM | 0.2% | YOY | -0.8% | +1.1% | |
TTM | 0.2% | 5Y | -0.1% | +0.4% | |
5Y | -0.1% | 10Y | -0.4% | +0.3% |
Compared to industry (Medical Devices)
Let compare the company's Return on Assets with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -2.2%. trending up. +2
- The TTM average (mean) in the Medical Devices industry is -3.2%. trending up. +2
4.3.1.3. Return on Equity
- Above 15%-20% is considered healthy but always compare Avanos to the Medical Devices industry mean.
- 0.3% Return on Equity means Avanos generated $0.00 for each $1 the owners (shareholders) invested.
Let's take a look of the Return on Equity trends of Avanos Medical Inc:
Trends
- The YOY is -1.1%. Compared to the TTM, the mid term is trending up. +2
- The 5Y is -0.2%. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -0.8%. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.3% | TTM | 0.3% | +0.0% | |
TTM | 0.3% | YOY | -1.1% | +1.5% | |
TTM | 0.3% | 5Y | -0.2% | +0.5% | |
5Y | -0.2% | 10Y | -0.8% | +0.7% |
Compared to industry (Medical Devices)
Let compare the company's Return on Equity with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -2.6%. trending up. +2
- The TTM average (mean) in the Medical Devices industry is -3.9%. trending up. +2
4.3.2. Operating Efficiency of Avanos Medical Inc.
4.3.2. Operating Efficiency
4.3.2.1. Operating Margin
- Measures how much profit Avanos makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
- Above 15% is considered healthy but always compare Avanos to the Medical Devices industry mean.
- An Operating Margin of 7.5% means the company generated $0.07 for each $1 in revenue (before taxes).
Let's take a look of the Operating Margin trends of Avanos Medical Inc:
Trends
- The YOY is 3.4%. Compared to the TTM, the mid term is trending up. +2
- The 5Y is 2.3%. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is 2.9%. Compared to the 5Y term, the 10Y term is trending down. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 7.5% | TTM | 7.4% | +0.0% | |
TTM | 7.4% | YOY | 3.4% | +4.0% | |
TTM | 7.4% | 5Y | 2.3% | +5.1% | |
5Y | 2.3% | 10Y | 2.9% | -0.7% |
Compared to industry (Medical Devices)
Let compare the company's Operating Margin with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -13.1%. trending up. +2
- The TTM average (mean) in the Medical Devices industry is -20.2%. trending up. +2
4.3.2.2. Operating Ratio
- Below 1 is considered healthy (always compare to Medical Devices industry mean).
- An Operation Ratio of 0.90 means that the operating costs are $0.90 for each $1 in net sales.
Let's take a look of the Operating Ratio trends of Avanos Medical Inc:
Trends
- The YOY is 0.968. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 0.975. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 0.947. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.902 | TTM | 0.909 | -0.007 | |
TTM | 0.909 | YOY | 0.968 | -0.059 | |
TTM | 0.909 | 5Y | 0.975 | -0.066 | |
5Y | 0.975 | 10Y | 0.947 | +0.028 |
Compared to industry (Medical Devices)
Let compare the company's Operating Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 1.213. trending down. +2
- The TTM average (mean) in the Medical Devices industry is 1.305. trending down. +2
4.4.3. Liquidity of Avanos Medical Inc.
4.4.3. Liquidity
4.4.3.1. Current Ratio
- Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
- A Current Ratio of 2.22 means the company has $2.22 in assets for each $1 in short-term debts.
Let's take a look of the Current Ratio trends of Avanos Medical Inc:
Trends
- The YOY is 2.946. Compared to the TTM, the mid term is trending down. -2
- The 5Y is 2.768. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 2.556. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 2.220 | TTM | 2.213 | +0.007 | |
TTM | 2.213 | YOY | 2.946 | -0.733 | |
TTM | 2.213 | 5Y | 2.768 | -0.554 | |
5Y | 2.768 | 10Y | 2.556 | +0.212 |
Compared to industry (Medical Devices)
Let compare the company's Current Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 2.567. trending down. -2
- The TTM average (mean) in the Medical Devices industry is 2.707. trending down. -2
4.4.3.2. Quick Ratio
- Above 1 is considered healthy but always compare Avanos to the Medical Devices industry mean.
- A Quick Ratio of 1.04 means the company can pay off $1.04 for each $1 in debt (using most liquid assets).
Let's take a look of the Quick Ratio trends of Avanos Medical Inc:
Trends
- The YOY is 1.508. Compared to the TTM, the mid term is trending down. -2
- The 5Y is 1.558. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 1.448. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 1.038 | TTM | 1.016 | +0.022 | |
TTM | 1.016 | YOY | 1.508 | -0.492 | |
TTM | 1.016 | 5Y | 1.558 | -0.542 | |
5Y | 1.558 | 10Y | 1.448 | +0.110 |
Compared to industry (Medical Devices)
Let compare the company's Quick Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 1.442. trending down. -2
- The TTM average (mean) in the Medical Devices industry is 1.678. trending down. -2
4.5.4. Solvency of Avanos Medical Inc.
4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio
- Below 1 (100%) is considered healthy but always compare Avanos to Medical Devices industry mean.
- A Debt to Asset Ratio of 0.26 means that Avanos assets are financed with 25.8% credit (debt) and the remaining percentage (100% - 25.8%) is financed by its owners/shareholders.
Let's take a look of the Debt to Asset Ratio trends of Avanos Medical Inc:
Trends
- The YOY is 0.270. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 0.264. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 0.334. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.258 | TTM | 0.263 | -0.005 | |
TTM | 0.263 | YOY | 0.270 | -0.007 | |
TTM | 0.263 | 5Y | 0.264 | -0.001 | |
5Y | 0.264 | 10Y | 0.334 | -0.070 |
Compared to industry (Medical Devices)
Let compare the company's Debt to Asset Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 0.401. trending down. +2
- The TTM average (mean) in the Medical Devices industry is 0.401. trending down. +2
4.5.4.2. Debt to Equity Ratio
- Below 2 is considered healthy but always compare Avanos to the Medical Devices industry mean.
- A Debt to Equity ratio of 34.7% means that company has $0.35 debt for each $1 in shareholders equity.
Let's take a look of the Debt to Equity Ratio trends of Avanos Medical Inc:
Trends
- The YOY is 0.370. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 0.360. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 0.532. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.347 | TTM | 0.356 | -0.010 | |
TTM | 0.356 | YOY | 0.370 | -0.014 | |
TTM | 0.356 | 5Y | 0.360 | -0.004 | |
5Y | 0.360 | 10Y | 0.532 | -0.172 |
Compared to industry (Medical Devices)
Let compare the company's Debt to Equity Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 0.565. trending down. +2
- The TTM average (mean) in the Medical Devices industry is 0.600. trending down. +2
4.6. Market Valuation
4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio
- Above 15 is considered overpriced but always compare Avanos to the Medical Devices industry mean.
- A PE ratio of 65.10 means the investor is paying $65.10 for every $1 in earnings.
Let's take a look of the Price to Earnings Ratio trends of Avanos Medical Inc:
Trends
- The YOY is -185.802. Compared to the TTM, the mid term is trending up. -2
- The 5Y is -38.965. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is -12.301. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
EOD | 48.686 | MRQ | 65.105 | -16.418 | |
MRQ | 65.105 | TTM | -9.356 | +74.460 | |
TTM | -9.356 | YOY | -185.802 | +176.446 | |
TTM | -9.356 | 5Y | -38.965 | +29.609 | |
5Y | -38.965 | 10Y | -12.301 | -26.664 |
Compared to industry (Medical Devices)
Let compare the company's Price to Earnings Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -1.351. trending up. +2
- The TTM average (mean) in the Medical Devices industry is -1.807. trending down. +2
4.6.2.2. Price To Free Cash Flow Ratio
Let's take a look of the Price To Free Cash Flow Ratio trends of Avanos Medical Inc:
- The EOD is 10.468. Based on how much money comes from the company's main activities, the company is cheap. +2
- The MRQ is 13.997. Based on how much money comes from the company's main activities, the company is cheap. +2
- The TTM is 10.987. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
- The YOY is -14.241. Compared to the TTM, the mid term is trending up. +2
- The 5Y is -28.471. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -44.665. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
EOD | 10.468 | MRQ | 13.997 | -3.530 | |
MRQ | 13.997 | TTM | 10.987 | +3.010 | |
TTM | 10.987 | YOY | -14.241 | +25.228 | |
TTM | 10.987 | 5Y | -28.471 | +39.458 | |
5Y | -28.471 | 10Y | -44.665 | +16.194 |
Compared to industry (Medical Devices)
Let compare the company's priceToFreeCashFlowRatio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is -1.910. trending up. +2
- The TTM average (mean) in the Medical Devices industry is -2.233. trending up. +2
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio
- At or below 1 is considered healthy (always compare to Medical Devices industry mean).
- A PB ratio of 0.91 means the investor is paying $0.91 for each $1 in book value.
Let's take a look of the Price to Book Ratio trends of Avanos Medical Inc:
Trends
- The YOY is 0.949. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 1.107. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 1.356. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
EOD | 0.681 | MRQ | 0.911 | -0.230 | |
MRQ | 0.911 | TTM | 0.815 | +0.096 | |
TTM | 0.815 | YOY | 0.949 | -0.134 | |
TTM | 0.815 | 5Y | 1.107 | -0.292 | |
5Y | 1.107 | 10Y | 1.356 | -0.249 |
Compared to industry (Medical Devices)
Let compare the company's Price to Book Ratio with the average (mean) in the Medical Devices industry:
- The MRQ average (mean) in the Medical Devices industry is 2.159. trending down. +2
- The TTM average (mean) in the Medical Devices industry is 2.344. trending down. +2
4.6.2. Total Gains per Share
4.7 Holders & Insider Transactions
Let's take a look at which institutions, funds and insiders are holding shares of Avanos Medical Inc.
4.8.1. Institutions holding Avanos Medical Inc
Institutions are holding 96.078% of the shares of Avanos Medical Inc.
Date | Name | Total Shares | Total Assets | Current Shares | Change | % |
---|---|---|---|---|---|---|
2024-06-30 | BlackRock Inc | 15.256 | 0.0032 | 7011219 | -248055 | -3.4171 |
2024-09-30 | Vanguard Group Inc | 11.5767 | 0.0023 | 5320302 | 50166 | 0.9519 |
2024-09-30 | RGM Capital LLC | 6.9009 | 3.2995 | 3171455 | 0 | 0 |
2024-09-30 | Dimensional Fund Advisors, Inc. | 5.6357 | 0.0151 | 2589985 | 12350 | 0.4791 |
2024-09-30 | T. Rowe Price Investment Management,Inc. | 5.1506 | 0.0343 | 2367045 | 149252 | 6.7298 |
2024-09-30 | Westwood Holdings Group Inc | 4.3324 | 0.2017 | 1991055 | -93062 | -4.4653 |
2024-09-30 | State Street Corp | 3.9643 | 0.0018 | 1821884 | -2451 | -0.1344 |
2024-09-30 | Brown Advisory Holdings Inc | 3.701 | 0.0513 | 1700876 | 30093 | 1.8011 |
2024-09-30 | William Blair Investment Management, LLC | 2.9976 | 0.0817 | 1377602 | -42393 | -2.9854 |
2024-09-30 | Paradice Investment Management LLC | 2.7466 | 5.2781 | 1262249 | -82700 | -6.1489 |
2024-09-30 | Morgan Stanley - Brokerage Accounts | 2.4641 | 0.002 | 1132447 | 414251 | 57.6794 |
2024-09-30 | Neuberger Berman Group LLC | 2.3213 | 0.02 | 1066814 | 68841 | 6.8981 |
2024-09-30 | Geode Capital Management, LLC | 2.2938 | 0.0021 | 1054162 | 16065 | 1.5475 |
2024-09-30 | Tributary Capital Management, LLC | 1.407 | 1.2066 | 646629 | -96427 | -12.9771 |
2024-09-30 | Prudential Financial Inc | 1.2767 | 0.0199 | 586730 | -34840 | -5.6052 |
2024-09-30 | Royal Bank of Canada | 1.2633 | 0.0029 | 580554 | -7323 | -1.2457 |
2024-09-30 | Charles Schwab Investment Management Inc | 1.1391 | 0.0024 | 523494 | -44734 | -7.8725 |
2024-09-30 | Northern Trust Corp | 1.0924 | 0.002 | 502043 | 5981 | 1.2057 |
2024-09-30 | Arrowstreet Capital Limited Partnership | 0.9899 | 0.0093 | 454931 | 357750 | 368.1275 |
2024-09-30 | Goldman Sachs Group Inc | 0.9105 | 0.0016 | 418417 | 240463 | 135.1265 |
Total | 77.4199 | 10.2378 | 35579893 | +693227 | +1.9% |
4.9.2. Funds holding Avanos Medical Inc
Date | Name | Total Shares | Total Assets | Current Shares | Change | % |
---|---|---|---|---|---|---|
2024-11-27 | iShares Core S&P Small-Cap ETF | 6.4423 | 0.06 | 2960673 | 1536 | 0.0519 |
2024-10-31 | Vanguard Total Stock Mkt Idx Inv | 3.1668 | 0.0016 | 1455382 | 2164 | 0.1489 |
2024-09-30 | T. Rowe Price Small-Cap Value | 3.0125 | 0.3064 | 1384449 | 0 | 0 |
2024-11-27 | iShares Russell 2000 ETF | 2.6926 | 0.0294 | 1237461 | -2590 | -0.2089 |
2024-10-31 | Vanguard Small Cap Index | 2.5113 | 0.0142 | 1154106 | 2250 | 0.1953 |
2024-10-31 | Brown Advisory Small-Cap Fdmtl Val Inv | 2.2151 | 1.3276 | 1017974 | -8934 | -0.87 |
2024-09-30 | Paradice Global Small Mid Cap Strategy | 1.7432 | 2.4314 | 801124 | 801124 | 0 |
2024-10-31 | Vanguard Small Cap Value Index Inv | 1.6941 | 0.0251 | 778556 | -268 | -0.0344 |
2024-09-30 | T. Rowe Price U.S. SC Value Eq Tr-Z | 1.6134 | 0.3053 | 741473 | 51532 | 7.469 |
2024-09-30 | Westwood Mgt SmallCap Value | 1.5431 | 1.4778 | 709156 | -75489 | -9.6208 |
2024-09-30 | Westwood Quality SmallCap Fund Inst | 1.5431 | 1.4799 | 709156 | -75489 | -9.6208 |
2024-10-31 | Vanguard Institutional Extnd Mkt Idx Tr | 1.4768 | 0.0117 | 678701 | -2301 | -0.3379 |
2024-09-30 | DFA US Small Cap Value I | 1.466 | 0.0967 | 673733 | 10994 | 1.6589 |
2024-10-31 | Tributary Small Cap Equity | 1.2507 | 1.1556 | 574786 | 101698 | 21.4966 |
2024-10-31 | William Blair Small Cap Value I | 1.1376 | 0.7725 | 522799 | -9234 | -1.7356 |
2024-11-27 | iShares S&P Small-Cap 600 Value ETF | 1.0208 | 0.1169 | 469145 | -1856 | -0.3941 |
2024-09-30 | Fidelity Small Cap Index | 1.0061 | 0.0405 | 462375 | -1975 | -0.4253 |
2024-11-27 | iShares Russell 2000 Value ETF | 0.9675 | 0.0611 | 444626 | 574 | 0.1293 |
2024-11-27 | SPDR® Portfolio S&P 600™ Sm Cap ETF | 0.9158 | 0.0605 | 420852 | 308 | 0.0732 |
2024-09-30 | Tributary Small Company Instl | 0.8189 | 1.1399 | 376330 | -94082 | -19.9999 |
Total | 38.2377 | 10.9141 | 17572857 | +699962 | +4.0% |
5.3. Insider Transactions
5. Financial Statements
5.1. Latest Balance Sheet
Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.
Summary
As reported | |
---|---|
Total Liabilities | 426,500 |
Total Stockholder Equity | + 1,229,700 |
Total Assets | = 1,656,200 |
Assets
Total Current Assets
Long-term Assets
Property Plant Equipment | 136,000 |
Goodwill | 795,100 |
Intangible Assets | 220,100 |
Long-term Assets Other | 25,800 |
Long-term Assets (as reported) | 1,183,600 |
---|---|
Long-term Assets (calculated) | 1,177,000 |
+/- | 6,600 |
Liabilities & Shareholders' Equity
Total Current Liabilities
Long-term Liabilities
Other
5.2. Balance Sheets Structured
Currency in USD. All numbers in thousands.
Trend | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
> Total Assets |
| 1,656,200 | 1,657,800 | 1,661,300 | 1,692,400 | 1,724,900 | 1,666,700 | 1,734,900 | 1,786,900 | 1,775,200 | 1,752,800 | 1,766,500 | 1,594,600 | 1,597,900 | 1,683,300 | 1,648,800 | 1,672,800 | 1,799,100 | 1,755,900 | 1,763,700 | 1,799,600 | 1,807,700 | 1,783,400 | 1,834,000 | 1,833,400 | 1,844,500 | 1,917,400 | 2,202,900 | 2,195,900 | 2,148,900 | 2,124,900 | 2,086,400 | 2,071,800 | 2,095,000 | 2,112,000 | 2,019,700 | 2,000,200 | 2,006,300 | 2,485,500 | 2,536,400 | 2,527,600 | 2,449,400 | 2,456,300 | 2,463,400 | 2,484,000 | 0 | 0 | 0 | 2,534,200 | ||||||||||||||||||||||||||||||||||||||||||||||||
> Total Current Assets |
| 472,600 | 474,100 | 467,800 | 487,000 | 524,600 | 506,900 | 453,800 | 499,800 | 470,000 | 437,100 | 439,200 | 418,600 | 405,000 | 443,500 | 447,900 | 467,200 | 567,600 | 517,100 | 524,100 | 538,500 | 546,500 | 572,500 | 660,000 | 713,600 | 737,200 | 876,500 | 1,161,100 | 1,160,700 | 681,000 | 654,800 | 614,400 | 593,500 | 605,600 | 609,700 | 706,600 | 676,000 | 666,000 | 653,100 | 703,100 | 684,900 | 596,100 | 598,300 | 571,400 | 585,100 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Cash And Cash Equivalents |
| 89,000 | 92,200 | 75,800 | 87,700 | 107,100 | 81,800 | 95,700 | 127,700 | 117,000 | 106,500 | 104,300 | 118,500 | 97,800 | 99,900 | 100,100 | 111,500 | 180,000 | 185,000 | 187,700 | 205,300 | 214,400 | 288,100 | 348,300 | 384,500 | 411,800 | 479,600 | 203,100 | 219,700 | 166,100 | 154,800 | 143,100 | 113,700 | 86,700 | 79,200 | 165,100 | 129,500 | 112,500 | 114,300 | 166,200 | 149,000 | 58,400 | 48,500 | 35,800 | 44,100 | 0 | 0 | 0 | 47,900 | ||||||||||||||||||||||||||||||||||||||||||||||||
Short-term Investments |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Net Receivables |
| 131,900 | 123,000 | 131,300 | 142,800 | 145,200 | 152,300 | 142,700 | 167,900 | 146,200 | 145,400 | 161,600 | 131,200 | 129,100 | 165,100 | 164,300 | 167,900 | 182,300 | 137,800 | 159,600 | 163,800 | 157,700 | 124,300 | 135,000 | 150,500 | 151,800 | 189,200 | 199,500 | 203,000 | 194,400 | 184,100 | 181,200 | 190,100 | 189,100 | 195,200 | 206,300 | 224,700 | 204,400 | 200,100 | 226,500 | 233,900 | 192,200 | 195,300 | 197,900 | 203,300 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Other Current Assets |
| 89,800 | 95,000 | 95,100 | 93,300 | 13,600 | 15,800 | 15,400 | 13,900 | 13,200 | 16,200 | 15,700 | 18,600 | 19,700 | 18,800 | 18,300 | 18,900 | 21,200 | 20,200 | 23,700 | 23,500 | 29,900 | 26,200 | 47,100 | 57,200 | 52,400 | 48,400 | 15,800 | 14,400 | 20,000 | 19,700 | 16,700 | 17,200 | 31,100 | 25,000 | 26,800 | 18,600 | 25,500 | 14,800 | 17,400 | 16,800 | 50,800 | 53,200 | 51,900 | 52,100 | 0 | 0 | 0 | 60,400 | ||||||||||||||||||||||||||||||||||||||||||||||||
> Long-term Assets |
| 1,183,600 | 1,183,700 | 1,193,500 | 1,205,400 | 1,200,300 | 1,159,800 | 1,281,100 | 1,287,100 | 1,305,200 | 1,315,700 | 1,327,300 | 1,176,000 | 1,192,900 | 1,239,800 | 1,200,900 | 1,205,600 | 1,231,500 | 1,238,800 | 1,239,600 | 1,261,100 | 1,261,200 | 1,210,900 | 1,174,000 | 1,119,800 | 1,107,300 | 1,040,900 | 1,041,800 | 1,035,200 | 1,467,900 | 1,470,100 | 1,472,000 | 1,478,300 | 1,489,400 | 1,502,300 | 1,313,100 | 1,324,200 | 1,340,300 | 1,832,400 | 1,833,300 | 1,842,700 | 1,853,300 | 1,858,000 | 1,892,000 | 1,898,900 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Property Plant Equipment |
| 136,000 | 140,100 | 140,400 | 144,000 | 143,900 | 151,700 | 191,800 | 194,500 | 195,900 | 198,200 | 203,000 | 206,700 | 211,100 | 214,800 | 218,500 | 223,600 | 233,800 | 239,300 | 238,600 | 248,500 | 246,100 | 241,600 | 214,500 | 154,100 | 137,000 | 123,500 | 117,500 | 109,900 | 261,100 | 259,700 | 258,300 | 260,800 | 265,000 | 272,600 | 275,600 | 279,500 | 282,100 | 286,000 | 281,800 | 277,800 | 292,800 | 284,900 | 326,000 | 324,900 | 0 | 0 | 0 | 325,700 | ||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill |
| 795,100 | 794,400 | 794,900 | 796,100 | 791,500 | 762,600 | 821,500 | 819,400 | 823,600 | 825,000 | 826,000 | 801,600 | 801,800 | 802,600 | 802,100 | 802,500 | 801,200 | 800,200 | 799,800 | 800,900 | 800,500 | 782,300 | 783,700 | 783,600 | 786,700 | 763,800 | 764,600 | 764,700 | 1,032,000 | 1,030,900 | 1,029,700 | 1,029,000 | 1,031,900 | 1,031,600 | 946,800 | 945,200 | 943,400 | 1,422,800 | 1,422,100 | 1,426,100 | 1,429,000 | 1,432,800 | 1,430,800 | 1,430,100 | 0 | 0 | 0 | 1,434,100 | ||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets |
| 220,100 | 226,200 | 232,800 | 239,500 | 242,200 | 222,600 | 244,700 | 251,000 | 258,700 | 264,900 | 271,100 | 141,200 | 145,300 | 149,500 | 153,600 | 157,700 | 170,100 | 174,600 | 179,300 | 184,300 | 189,500 | 158,500 | 163,200 | 168,200 | 173,900 | 139,500 | 144,600 | 148,900 | 154,800 | 159,800 | 164,400 | 169,800 | 176,700 | 182,400 | 77,400 | 82,600 | 89,000 | 95,400 | 101,800 | 108,300 | 116,300 | 125,100 | 132,500 | 141,200 | 0 | 0 | 0 | 1,610,900 | ||||||||||||||||||||||||||||||||||||||||||||||||
Long-term Assets Other |
| 25,800 | 16,700 | 19,100 | 19,300 | 18,400 | 18,500 | 18,600 | 17,600 | 16,100 | 16,500 | 15,900 | 16,500 | 11,100 | 11,000 | 11,300 | 11,800 | 14,400 | 10,700 | 10,900 | 11,300 | 12,800 | 15,200 | 6,400 | 7,600 | 3,400 | 3,500 | 3,800 | 4,100 | 3,700 | 3,600 | 3,800 | 3,600 | 3,600 | 3,700 | 2,000 | 2,000 | 25,800 | 28,200 | 27,600 | 30,500 | 15,200 | 15,200 | 2,700 | 2,700 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Long Term Asset Charges |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,200 | 12,000 | 11,300 | 14,900 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
> Total Liabilities |
| 426,500 | 435,800 | 433,400 | 456,100 | 502,800 | 431,900 | 436,200 | 495,700 | 511,700 | 501,200 | 510,000 | 330,700 | 336,000 | 387,000 | 396,200 | 416,300 | 509,200 | 494,300 | 507,200 | 534,400 | 540,800 | 506,500 | 553,900 | 536,200 | 544,300 | 630,800 | 951,100 | 980,500 | 968,200 | 968,100 | 955,500 | 969,300 | 993,500 | 1,022,500 | 939,900 | 944,900 | 965,300 | 963,700 | 1,024,600 | 1,036,400 | 370,400 | 379,000 | 359,900 | 404,900 | 0 | 0 | 0 | 478,500 | ||||||||||||||||||||||||||||||||||||||||||||||||
> Total Current Liabilities |
| 212,900 | 208,200 | 205,200 | 234,600 | 170,700 | 160,500 | 158,500 | 185,800 | 162,300 | 151,100 | 152,900 | 139,200 | 129,200 | 158,300 | 154,600 | 166,300 | 179,400 | 176,000 | 189,400 | 212,500 | 218,100 | 187,000 | 238,400 | 264,300 | 265,500 | 352,800 | 360,600 | 389,800 | 319,400 | 321,800 | 310,000 | 324,400 | 310,700 | 304,900 | 309,300 | 315,200 | 326,800 | 324,000 | 341,000 | 356,000 | 277,900 | 283,800 | 265,300 | 310,400 | 0 | 0 | 0 | 359,100 | ||||||||||||||||||||||||||||||||||||||||||||||||
Short-term Debt |
| 23,100 | 39,000 | 20,900 | 34,200 | 18,900 | 19,700 | 18,300 | 19,000 | 19,600 | 18,200 | 14,500 | 14,700 | 14,700 | 14,900 | 15,100 | 15,500 | 15,600 | 15,400 | 14,300 | 14,700 | 14,500 | 14,700 | 11,700 | 0 | 0 | 247,400 | 542,000 | 39,800 | 580,400 | 579,900 | 0 | 579,000 | 0 | 0 | 0 | 578,100 | 0 | 0 | 3,900 | 3,900 | 10,900 | 10,400 | 9,400 | 11,900 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Short Long Term Debt |
| 9,400 | 10,200 | 9,400 | 8,600 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 4,700 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11,700 | 0 | 0 | 247,400 | 542,000 | 39,800 | 580,400 | 579,900 | 0 | 579,000 | 0 | 0 | 0 | 578,100 | 0 | 0 | 0 | 3,900 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Accounts payable |
| 54,200 | 51,400 | 57,000 | 56,300 | 52,100 | 65,400 | 59,600 | 67,900 | 62,700 | 64,200 | 63,800 | 56,400 | 54,900 | 65,500 | 59,200 | 67,600 | 75,900 | 75,800 | 73,500 | 83,000 | 94,700 | 99,400 | 148,800 | 169,900 | 159,200 | 176,900 | 194,400 | 171,200 | 172,500 | 184,400 | 179,700 | 173,100 | 166,500 | 168,600 | 181,100 | 163,200 | 179,100 | 200,600 | 192,100 | 168,700 | 118,400 | 121,000 | 113,500 | 118,500 | 0 | 0 | 0 | 102,200 | ||||||||||||||||||||||||||||||||||||||||||||||||
Other Current Liabilities |
| 129,400 | 111,700 | 92,300 | 127,400 | 2,500 | 2,700 | 80,600 | 98,900 | 80,000 | 68,700 | 74,600 | 68,100 | 57,800 | 75,900 | 76,900 | 80,500 | 85,900 | 80,400 | 98,300 | 111,600 | 105,100 | 68,700 | 11,700 | 94,400 | 106,300 | 175,900 | 166,200 | 33,900 | 146,900 | 137,400 | 130,300 | 151,300 | 144,200 | 136,300 | 128,200 | 152,000 | 147,700 | 123,400 | 121,200 | 181,300 | 142,600 | 140,500 | 131,200 | 167,800 | 0 | 0 | 0 | 160,300 | ||||||||||||||||||||||||||||||||||||||||||||||||
> Long-term Liabilities |
| 213,600 | 227,600 | 228,200 | 221,500 | 332,100 | 271,400 | 277,700 | 309,900 | 349,400 | 350,100 | 357,100 | 191,500 | 206,800 | 228,700 | 241,600 | 250,000 | 329,800 | 318,300 | 317,800 | 321,900 | 322,700 | 319,500 | 315,500 | 271,900 | 278,800 | 278,000 | 590,500 | 590,700 | 648,800 | 646,300 | 645,500 | 644,900 | 682,800 | 717,600 | 630,600 | 629,700 | 638,500 | 639,700 | 683,600 | 680,400 | 92,500 | 95,200 | 94,600 | 94,500 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Long term Debt Total |
| 0 | 0 | 0 | 0 | 0 | 0 | 204,700 | 226,300 | 247,800 | 249,300 | 254,400 | 130,000 | 145,000 | 165,000 | 175,000 | 180,000 | 248,500 | 248,400 | 248,200 | 248,100 | 247,900 | 247,800 | 247,900 | 247,700 | 247,600 | 247,400 | 542,000 | 541,100 | 580,400 | 579,900 | 579,400 | 579,000 | 589,400 | 624,000 | 578,500 | 578,100 | 585,900 | 585,800 | 631,400 | 632,300 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Capital Lease Obligations Min Short Term Debt |
| 17,100 | 4,200 | 17,200 | 6,900 | 23,300 | 24,700 | 26,200 | 28,500 | 30,600 | 33,700 | 40,000 | 42,800 | 46,100 | 47,500 | 50,100 | 53,300 | 56,100 | 58,900 | 58,800 | 62,600 | 62,500 | 65,500 | 57,700 | 0 | 0 | -247,400 | -542,000 | -39,800 | -580,400 | -579,900 | 0 | -579,000 | 0 | 0 | 0 | -578,100 | 0 | 0 | -3,900 | -3,900 | -10,900 | -10,400 | -9,400 | -11,900 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Long Term Asset Charges |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,200 | 12,000 | 11,300 | 14,900 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Long-term Liabilities Other |
| 3,900 | 3,900 | 4,100 | 4,100 | 15,600 | 15,400 | 15,500 | 18,700 | 64,600 | 23,500 | 68,000 | 51,900 | 56,200 | 4,900 | 61,000 | 64,300 | 67,500 | 69,900 | 69,600 | 73,800 | 74,300 | 71,100 | 63,200 | 19,800 | 30,100 | 29,600 | 30,200 | 31,800 | 31,900 | 30,000 | 29,900 | 30,100 | 30,000 | 30,200 | 28,200 | 27,800 | 0 | 0 | 0 | 48,100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Long Term Liability |
| 0 | 0 | 0 | 0 | 0 | 21,800 | 25,100 | 25,400 | 37,000 | 34,700 | 34,700 | 9,600 | 5,600 | 5,600 | 5,600 | 5,700 | 13,800 | 0 | 0 | 0 | 500 | 600 | 4,400 | 4,400 | 1,100 | 1,000 | 18,300 | 17,800 | 36,500 | 36,400 | 36,200 | 35,800 | 63,400 | 63,400 | 23,900 | 23,800 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
> Total Stockholder Equity |
| 1,229,700 | 1,222,000 | 1,227,900 | 1,236,300 | 1,222,100 | 1,234,800 | 1,298,700 | 1,291,200 | 1,263,500 | 1,251,600 | 1,256,500 | 1,263,900 | 1,261,900 | 1,296,300 | 1,252,600 | 1,256,500 | 1,289,900 | 1,261,600 | 1,256,500 | 1,265,200 | 1,266,900 | 1,276,900 | 1,280,100 | 1,297,200 | 1,300,200 | 1,286,600 | 1,251,800 | 1,215,400 | 1,180,700 | 1,156,800 | 1,130,900 | 1,102,500 | 1,101,500 | 1,089,500 | 1,079,800 | 1,055,300 | 1,041,000 | 1,521,800 | 1,511,800 | 1,491,200 | 2,079,000 | 2,077,300 | 2,103,500 | 2,079,100 | 0 | 0 | 0 | 2,055,700 | ||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
| 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Retained Earnings Total Equity |
| 0 | 0 | 0 | 0 | 0 | -321,700 | -253,600 | -253,100 | -270,000 | -293,100 | -304,500 | -310,300 | -320,300 | -285,200 | -323,100 | -315,500 | -268,300 | -287,600 | -284,600 | -288,300 | -282,200 | -270,700 | -262,700 | -242,400 | -240,200 | -244,400 | -279,700 | -299,900 | -332,700 | -349,300 | -366,400 | -379,200 | -389,200 | -398,300 | -404,800 | -419,000 | -433,600 | 36,900 | 29,000 | 7,300 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income | -36,900 | -37,500 | -29,500 | -27,000 | -33,000 | -28,400 | -35,800 | -35,800 | -42,900 | -37,800 | -32,100 | -33,800 | -33,600 | -30,000 | -32,300 | -28,100 | -37,100 | -42,000 | -46,900 | -32,000 | -34,800 | -31,100 | -33,000 | -33,700 | -30,500 | -32,100 | -21,800 | -31,300 | -30,600 | -34,300 | -39,400 | -50,100 | -38,300 | -38,100 | -36,600 | -43,200 | -42,800 | -28,900 | -25,600 | -19,100 | -21,100 | -11,600 | -14,600 | -19,600 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Capital Surplus |
| 0 | 0 | 0 | 0 | 0 | 1,654,900 | 1,651,000 | 1,646,400 | 1,642,300 | 1,637,400 | 1,633,300 | 1,628,800 | 1,625,700 | 1,621,300 | 1,617,300 | 1,609,400 | 1,604,100 | 1,599,900 | 1,596,400 | 1,593,900 | 1,592,100 | 1,586,800 | 1,582,500 | 1,578,100 | 1,575,500 | 1,567,700 | 1,557,300 | 1,550,500 | 1,547,400 | 1,543,800 | 1,538,100 | 1,533,200 | 1,530,400 | 1,527,300 | 1,521,700 | 1,518,000 | 1,517,900 | 1,514,300 | 1,507,900 | 1,502,500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -40,700 | -21,300 | -10,400 | -10,300 | -9,800 | -9,800 | -9,300 | -9,200 | -8,900 | -8,900 | -8,700 | -8,600 | -7,200 | -5,300 | -5,100 | -5,100 | -4,500 | -4,400 | -3,900 | -3,900 | -1,900 | -1,900 | -1,900 | -1,900 | -1,000 | -1,000 | -1,000 | -1,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Other Stockholders Equity |
| 1,575,800 | 1,573,000 | 1,572,700 | 1,577,700 | 1,580,000 | 1,584,400 | 1,587,100 | 1,579,600 | 1,575,900 | 1,582,000 | 1,592,600 | 1,607,500 | 1,615,300 | 1,611,000 | 1,607,500 | 1,599,600 | 1,594,800 | 1,590,700 | 1,587,500 | 1,585,000 | 1,583,400 | 1,578,200 | 1,575,300 | 1,572,800 | 1,570,400 | 1,562,600 | 1,552,800 | 1,546,100 | 1,543,500 | 1,539,900 | 1,536,200 | 1,531,300 | 1,528,500 | 1,525,400 | 1,520,700 | 1,517,000 | 1,516,900 | 1,513,300 | 1,507,900 | 1,502,500 | 2,100,100 | 2,088,900 | 2,118,100 | 2,098,700 | 0 | 0 | 0 | 0 |
5.3. Balance Sheets
Currency in USD. All numbers in thousands.
5.4. Cash Flows
Currency in USD. All numbers in thousands.